Generation of a conditional null allele for Cftr in mice.
about
Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease.The impact of Cystic Fibrosis Transmembrane Regulator Disruption on cardiac function and stress response.Eccrine sweat gland development and sweat secretionNeutrophil-mediated phagocytic host defense defect in myeloid Cftr-inactivated mice.Parasympathetic innervation regulates tubulogenesis in the developing salivary gland.Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.Subfertility and growth restriction in a new galactose-1 phosphate uridylyltransferase (GALT) - deficient mouse modelAnimal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology.Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy.Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium.Nucleosome occupancy reveals regulatory elements of the CFTR promoter.Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection.Growth deficits in cystic fibrosis mice begin in utero prior to IGF-1 reduction.Intestinal smooth muscle dysfunction develops postnatally in cystic fibrosis miceNew animal models of cystic fibrosis: what are they teaching us?Comparative biology of cystic fibrosis animal modelsCFTR is a tumor suppressor gene in murine and human intestinal cancerLipids in cystic fibrosis.Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses.Cystic fibrosis-related diabetes is caused by islet loss and inflammation.Kcnn4 is a modifier gene of intestinal cystic fibrosis preventing lethality in the Cftr-F508del mouse.A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies.
P2860
Q30416347-1455ECBD-E484-432E-A2D2-A1E7040855E4Q30692395-97FE6966-4214-4FEE-9355-62DBE2F2A630Q33901945-3891D880-BAD7-4A36-AD14-2E7D4BA1B4BCQ34128926-D109B5F6-41AB-4C8E-A427-B193A883A8A5Q34138618-C94F1F41-B1EB-4695-AA7E-9FEF0C04BAC7Q34205956-E25AFB79-6C72-445D-99F5-51C5EB423B76Q34215656-307739E0-6316-4C59-A55B-3F0DC3BF8B11Q35178642-62479090-A029-4D8E-9400-AA531A058E42Q35200182-D4BC02FC-1FD4-4ED4-9FF5-6CAFA6136AA0Q35216745-AF292908-2FEF-4258-A670-AEE12187E152Q35672247-A7E2071D-CC8D-4D30-B742-667733010EC3Q36332718-1F1B3ADF-A634-4978-8D8E-264D4EDA589EQ36338302-C5BA2A60-2A13-457B-BFB0-78B4EB7A3E99Q36418541-E878E9D6-CD75-4988-916A-030AD702A861Q36679834-2D8DB212-BD5E-4B76-AC4F-A483CA045304Q36744020-DC8C01CB-1A1C-4507-A017-C2C183B4B0A3Q37083588-2A0AABC3-9F25-4A71-8287-2250E2DB11A7Q37920895-54DEEE16-F7C7-4364-931C-D439B05630A0Q41819454-6E20A21C-F321-42AD-8BEE-CE8CDBE26F27Q52579658-AD84D084-1E0C-48F0-853D-23D7C4FAC8FAQ55396999-71D69467-3EC3-4927-A391-7001C5BE4D0CQ55437233-B63FD743-0458-4EB4-BB96-C05DAB7756A6
P2860
Generation of a conditional null allele for Cftr in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Generation of a conditional null allele for Cftr in mice.
@en
Generation of a conditional null allele for Cftr in mice.
@nl
type
label
Generation of a conditional null allele for Cftr in mice.
@en
Generation of a conditional null allele for Cftr in mice.
@nl
prefLabel
Generation of a conditional null allele for Cftr in mice.
@en
Generation of a conditional null allele for Cftr in mice.
@nl
P2093
P2860
P356
P1433
P1476
Generation of a conditional null allele for Cftr in mice.
@en
P2093
Calvin U Cotton
Craig A Hodges
Mark R Palmert
Mitchell L Drumm
P2860
P304
P356
10.1002/DVG.20433
P577
2008-10-01T00:00:00Z